Advertisement

Topics

Crystals of the brain.

06:00 EST 27th January 2011 | BioPortfolio

Summary of "Crystals of the brain."

No Summary Available

Affiliation

Norwegian University of Science and Technology, Trondheim, Norway.

Journal Details

This article was published in the following journal.

Name: EMBO molecular medicine
ISSN: 1757-4684
Pages:

Links

DeepDyve research library

PubMed Articles [7114 Associated PubMed Articles listed on BioPortfolio]

Control of the wetting properties of ^{4}He crystals in superfluid.

To investigate whether it is possible to control the wetting of ^{4}He crystals on a wall in superfluid, the contact angles of ^{4}He crystals were measured on rough and smooth walls at very low tempe...

Cholesterol crystals activate Syk and PI3 kinase in human macrophages and dendritic cells.

Cholesterol crystals are a key component of atherosclerotic lesions where they promote pro-inflammatory cytokine production and plaque destabilization. Antagonists of inflammatory mediators and agents...

Size-controlled 3D colloidal crystals formed in aqueous suspension of polystyrene/polyglycidol microspheres with covalently bound L-DOPA.

Stable three-dimensional colloidal crystals were fabricated in aqueous suspension of Tris buffer at pH>8. The basic building blocks of the crystals were the submicron-sized polystyrene-polyglycidol co...

Highly Sensitive Coherent anti-Stokes Raman Scattering Imaging of Protein Crystals.

Serial crystallography at last generation X-ray synchrotron sources and free electron lasers enabled data collection with micrometer and even sub-micrometer size crystals which have resulted in amazin...

High-efficiency broadband anti-Stokes emission from Yb3+-doped bulk crystals.

We investigate the broadband anti-Stokes emission (BASE) from Yb3+-doped crystals with a laser diode (LD) pumping at 940 nm. Our experiment reveals that Yb3+-doped crystals with random cracks are able...

Clinical Trials [2693 Associated Clinical Trials listed on BioPortfolio]

Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis

This study will continue to evaluate the long term safety and effectiveness of cysteamine eye drops for treating cystine crystals in the corneas of patients with cystinosis. These drops a...

Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20)

The study is a 2 arm, multi-center, randomized, open-labeled clinical trial designed to assess the effects of varying doses and schedules of oral insulin on immunological and metabolic mar...

Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers

Prospective, open, mono-center, randomized, two part study with 4-way cross-over design in each study part. The objective of the study is to investigate blood glucose levels after oral in...

New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis

This study will evaluate the safety and effectiveness of a new formulation of eye drops used to treat cystine crystals that form in the corneas of patients with cystinosis. Cystinosis is ...

Monitoring Brain Activity in Human Brain Injury

The outcome of brain injury (physical or stroke) may be related to a brain electrical phenomenon known as Cortical Spreading Depression (CSD). This is a brief cessation of function in a l...

Medical and Biotech [MESH] Definitions

Tissue NECROSIS in any area of the brain, including the CEREBRAL HEMISPHERES, the CEREBELLUM, and the BRAIN STEM. Brain infarction is the result of a cascade of events initiated by inadequate blood flow through the brain that is followed by HYPOXIA and HYPOGLYCEMIA in brain tissue. Damage may be temporary, permanent, selective or pan-necrosis.

Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.

Bleeding within the brain as a result of penetrating and nonpenetrating CRANIOCEREBRAL TRAUMA. Traumatically induced hemorrhages may occur in any area of the brain, including the CEREBRUM; BRAIN STEM (see BRAIN STEM HEMORRHAGE, TRAUMATIC); and CEREBELLUM.

A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.

Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Quick Search
Advertisement
 


DeepDyve research library

Relevant Topic

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...